Clinical trials: Cardiopulmonary-bypass
Acute Circulatory Failure
Microcirculatory Effects of Methylene Blue
International guidelines recommend Methylene Blue (MB) as a second-line drug in the treatment of norepinephrine refractory vasoplegic shock (VS) after Cardiopulmonary Bypass CPB.
- Trial name
- MAGIC BLUE (NCT04250389)
- Testing
- Hemodynamic assessment (micro and macrocirculatory)
- Where
- France
- Volunteers
- 25 people
- Sponsor
- Hospices Civils de Lyon
Cardiovascular Diseases, Heart Diseases
Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery
This study will determine the pharmacokinetics and safety of intravenous citrulline given to children undergoing cardiopulmonary bypass for the correction of congenital heart defects.
- Conditions
- Cardiovascular Diseases, Heart Diseases, Heart Defects, Congenital
- Trial name
- NCT00201214
- Testing
- Citrulline
- Where
- United States
- Volunteers
- 26 people
- Sponsor
- Vanderbilt University